LAURUS LABS LIMITED
63Patents
63Active
63Granted
53Portfolio score
Filing activity: Jul 30, 2008 → Jul 5, 2022 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9834577B2 | Process for the preparation of gemcitabine-[phenyl(benzoxy-L-alaninyl)] phosphate | Chemistry; Metallurgy | 17 | Active |
| US8513236B2 | Pterostilbene cocrystals | Chemistry; Metallurgy | 12 | Active |
| US8415507B2 | Pterostilbene cocrystals | Chemistry; Metallurgy | 11 | Active |
| US10774104B2 | Diastereoselective synthesis of phosphate derivatives | Emerging Cross-Sectional Technologies | 4 | Active |
| US10428053B2 | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof | Chemistry; Metallurgy | 3 | Active |
| US8318807B2 | Pterostilbene cocrystals | Chemistry; Metallurgy | 2 | Active |
| US8399712B2 | Pterostilbene cocrystals | Chemistry; Metallurgy | 2 | Active |
| US9573902B2 | Process for the preparation of Ivacaftor and its intermediates | Chemistry; Metallurgy | 2 | Active |
| US9487487B2 | Process for preparation of montelukast sodium | Human Necessities | 1 | Active |
| US8207343B2 | Process for preparing montelukast and salts thereof | Chemistry; Metallurgy | 1 | Active |
| US9957234B2 | Polymorphs of Ivacaftor, process for its preparation and pharmaceutical composition thereof | Chemistry; Metallurgy | 1 | Active |
| US8367834B2 | Process for preparing Montelukast and salts thereof | Chemistry; Metallurgy | 1 | Active |
| US11040961B2 | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof | Chemistry; Metallurgy | 0 | Active |
| US9073817B2 | Efficient process to induce enantioselectivity in procarbonyl compounds | Chemistry; Metallurgy | 0 | Active |
| US9156885B2 | Process for preparing eptifibatide | Human Necessities | 0 | Active |
| US9156756B2 | Efficient process to induce enantioselectivity in procarbonyl compounds | Chemistry; Metallurgy | 0 | Active |
| US11634431B2 | Process for purification of protected polycyclic carbamoylpyridone derivatives | Chemistry; Metallurgy | 0 | Active |
| US10301321B2 | Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof | Chemistry; Metallurgy | 0 | Active |
| US9056882B2 | Process for the preparation of tenofovir | Human Necessities | 0 | Active |
| US11434196B2 | Process for preparation of 2-Amino-5-hydroxy propiophenone | Chemistry; Metallurgy | 0 | Active |
| US8524782B2 | Key intermediate for the preparation of Stilbenes, solid forms of Pterostilbene, and methods for making the same | Chemistry; Metallurgy | 0 | Active |
| US9206163B2 | Process for the preparation of sunitinib and its acid addition salts thereof | Chemistry; Metallurgy | 0 | Active |
| US10857132B2 | Stable amorphous form of sacubitril valsartan trisodium complex and processes for preparation thereof | Chemistry; Metallurgy | 0 | Active |
| US12065426B2 | Crystalline form of nilotinib hydrochloride, process for its preparation and pharmaceutical composition containing the same | Chemistry; Metallurgy | 0 | Active |
| US10214538B2 | Process for preparation of Darunavir | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.